Jean-Hugues S.
- Country
- France
- Department
- Department of Rheumatology
Research Overview
- Comparison of Bimekizumab versus Adalimumab for the Treatment of Anterior Chest Wall Pain in Patients with Active Axial Spondyloarthritis Refractory to NSAIDs
- Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Adults With Active Psoriatic Arthritis: A Phase 3 Extension Study
- Open-Label Extension Study Evaluating Long-Term Safety and Tolerability of Subcutaneous Secukinumab in Patients with Polymyalgia Rheumatica
Data & Insights
Has run more than one trial at 102 of 240 partner sites.
Specializations
Rheumatoid Arthritis Management
The investigator specializes in innovative approaches to rheumatoid arthritis treatment, with particular focus on biological therapies and JAK inhibitors.
- Comparative biologic treatments
- Dose optimization strategies
- Maintenance therapy protocols
Research encompasses the evaluation of treatment combinations and tapering strategies for patients with varying response levels.
Inflammatory Arthritis
Expertise extends to various forms of inflammatory joint conditions, including psoriatic arthritis and polymyalgia rheumatica.
- Novel therapeutic approaches
- Long-term safety assessments
- Treatment optimization studies
Focus on developing targeted treatments for inflammatory joint conditions with emphasis on patient outcomes.
Metabolic Joint Disorders
The investigator conducts research in gout management and treatment optimization strategies for metabolic joint disorders.
- Treatment withdrawal studies
- Remission monitoring
- Long-term disease management
Expertise in ultrasound-guided monitoring and treatment modification in metabolic joint conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.